Discontinued — last reported Q4 '24
Business Segments · Total revenues
Corporate — Total revenues
McKesson Corporate — Total revenues increased by 33.3% to $4.00M in Q4 2024 compared to the prior quarter.
Analysis
StatementSegment
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2023
Last reportedQ4 2024
Rolls up toTotal Revenue
How to read this metric
An increase may indicate higher intercompany service charges or non-core business activity, while a decrease often reflects reduced corporate-level revenue recognition or changes in internal cost allocation policies.
Detailed definition
This metric represents the total gross revenue generated by the corporate segment, which typically encompasses centraliz...
Peer comparison
Peer companies in the pharmaceutical wholesale industry often report corporate segments with minimal revenue, as these segments are primarily cost centers; significant revenue here is usually an outlier compared to competitors like Cencora or Cardinal Health.
Metric ID:
mck_segment_corporate_total_revenuesHistorical Data
4 periods
| Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|
| Value | $0.00 | $0.00 | $3.00M | $4.00M |
| QoQ Change | — | — | — | +33.3% |
Range$0.00 – $4.00M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's corporate — total revenues?
- McKesson (MCK) reported corporate — total revenues of $4.00M in Q4 2024.
- What does corporate — total revenues mean?
- The total revenue reported by the company's corporate-level administrative and non-operating business segment.